Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Lip Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Platinum 2Cisplatin 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2vandetanib 1temsirolimus 1ficlatuzumab 1durvalumab 1dehydroftorafur 1adavosertib 1X-Rays 1Trioxsalen 1Soybean Proteins 1Sirolimus 1Phototherapy 1Photochemotherapy 1Paclitaxel 1Methods 1Metformin 1Immunohistochemistry 1Immunoglobulin G 1Gemcitabine 1Gefitinib 1Fluorouracil 1Educational Status 1Docetaxel 1Disulfides 1Dihematoporphyrin Ether 1Carboplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoid Interstitial Pneumonia × ficlatuzumab × Clear all
NCT03422536 2024-09-04

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

University of Arizona

Phase 2 Completed
78 enrolled 16 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡